Send to:

Choose Destination
See comment in PubMed Commons below
Org Lett. 2010 Apr 16;12(8):1744-7. doi: 10.1021/ol100342m.

Engineering of Streptomyces platensis MA7339 for overproduction of platencin and congeners.

Author information

  • 1Division of Pharmaceutical Sciences, University of Wisconsin, Madison, Wisconsin 53705, USA.


Platensimycin (1) and platencin (2) are novel antibiotic leads against multidrug resistant pathogens. The production of 2 in Streptomyces platensis MA7339 is under the control of ptnR1, a GntR-like transcriptional regulator. Inactivating ptnR1 afforded S. platensis MA7339 mutant strain SB12600 that overproduces 2 at a titer approximately 100-fold greater than that from the wild-type strain and accumulates platencin A(1) (3) and eight new congeners, platencins A(2)-A(9) (4-11). The isolation, structural elucidation, and antibacterial activity of 4-11, in comparison to 1-3, are described.

[PubMed - indexed for MEDLINE]
Free PMC Article
PubMed Commons home

PubMed Commons

How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for American Chemical Society Icon for PubMed Central
    Loading ...
    Write to the Help Desk